(Q43116207)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20349094%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20349094%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20349094%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Aideen M Sullivan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20349094%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

David B O'Sullivan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20349094%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

27 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20349094%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neural Transmission

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20349094%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20349094%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20349094%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

559-572

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20349094%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00702-010-0392-9

29 January 2020

exact match

0 references

cites work

Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-010-0392-9

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-010-0392-9

A review of recent advances in stereology for quantifying neural structure

21 January 2018

1 reference

12 December 2020

Progress in Parkinson's disease-where do we stand?

1 reference

12 December 2020

Sustained delivery of GDNF: towards a treatment for Parkinson's disease

1 reference

12 December 2020

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model

1 reference

12 December 2020

Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons

1 reference

12 December 2020

Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons

1 reference

12 December 2020

A rat embryo staging scale for the generation of donor tissue for neural transplantation

1 reference

12 December 2020

Cloning and expression of recombinant human growth/differentiation factor 5

1 reference

12 December 2020

In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease

1 reference

12 December 2020

Improving the transfection efficiency of post-mitotic neurons.

1 reference

12 December 2020

Survival assay of transiently transfected dopaminergic neurons.

1 reference

12 December 2020

Effects of growth/differentiation factor 5 on the survival and morphology of embryonic rat midbrain dopaminergic neurones in vitro

1 reference

12 December 2020

Crossroads in GDNF therapy for Parkinson's disease

1 reference

12 December 2020

Differential effects of GDF5 on the medial and lateral rat ventral mesencephalon.

1 reference

12 December 2020

Cell therapy for Parkinson's disease: problems and prospects.

1 reference

12 December 2020

Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease.

1 reference

12 December 2020

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease

1 reference

12 December 2020

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

1 reference

12 December 2020

Transplanted dopaminergic neurons develop PD pathologic changes: a second case report

1 reference

12 December 2020

Strategies for the augmentation of grafted dopamine neuron survival

1 reference

12 December 2020

TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity

1 reference

12 December 2020

Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease

1 reference

12 December 2020

GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats

1 reference

12 December 2020

Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease.

1 reference

12 December 2020

Improving the survival of grafted dopaminergic neurons: a review over current approaches.

1 reference

12 December 2020

Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study.

1 reference

12 December 2020

Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat.

1 reference

12 December 2020

Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective

1 reference

12 December 2020

Toxic effects of lipid-mediated gene transfer in ventral mesencephalic explant cultures.

1 reference

12 December 2020

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

1 reference

12 December 2020

Lazaroids improve the survival of grafted rat embryonic dopamine neurons

1 reference

12 December 2020

GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo

1 reference

12 December 2020

Techniques for gene transfer into neurons.

1 reference

12 December 2020

Factors affecting the clinical outcome after neural transplantation in Parkinson's disease

1 reference

12 December 2020

Neuroprotective effects of growth/differentiation factor 5 depend on the site of administration.

1 reference

12 December 2020

Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain

1 reference

12 December 2020

Neural transplantation for the treatment of Parkinson's disease

1 reference

12 December 2020

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

1 reference

12 December 2020

Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor

1 reference

12 December 2020

Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium.

1 reference

12 December 2020

Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease

1 reference

12 December 2020

Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion

1 reference

12 December 2020

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

1 reference

12 December 2020

Expression of growth differentiation factor-5 in the developing and adult rat brain.

1 reference

12 December 2020

GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts

1 reference

12 December 2020

Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson's disease.

1 reference

12 December 2020

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

12 December 2020

Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion

1 reference

12 December 2020

Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts

1 reference

12 December 2020

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

1 reference

12 December 2020

Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.

1 reference

12 December 2020

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

1 reference

12 December 2020

Emerging restorative treatments for Parkinson's disease

1 reference

12 December 2020

Clinical observations after neural transplantation in Parkinson's disease

1 reference

12 December 2020

Cell therapy in Parkinson's disease - stop or go?

1 reference

12 December 2020

Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo

1 reference

12 December 2020

The cellular repair of the brain in Parkinson's disease--past, present and future.

1 reference

12 December 2020

Convective delivery of glial cell line-derived neurotrophic factor in the human putamen

1 reference

12 December 2020